BridgeMD
New treatment option for Tinnitus, Subjective
Official title Neuromodulatory Effects of Audio-proprio-phonatory Reinforcement Training on Subjective Tinnitus, Demonstrated by High-density Electroencephalogram (HD EEG)
ClinicalTrials.gov ID: NCT06880367
What this study is testing
- What it's testing
- Our ecological approach to neuromodulation in the field of "acouphonology" empowers tinnitus patients to act as their own source of sound stimuli through audio-proprio-phonatory reinforcement (APPR). By engaging in self-phonations, individuals uncoverthe vast potential for sound production, which can effectively mask their tinnitus or induce residual inhibition, all without relying on external sources.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 84
You may be able to join if
- Person who agreed to participate in the study and gave consent
- Aged ≥ 18 years and \< 85 years
- Suffering from subjective tinnitus for more than 3 months
- Have a score on the THI questionnaire taken at T0 greater than or equal to 38
- Be equipped with a smartphone compatible with the Siopi application and a computer connection for videoconference sessions
You likely can't join if
- Patient suffering from objective tinnitus
- Current port of white noise generators
- Patient having consulted phoniatrics more than twice or having participated in more than two sound-mediated workshop sessions
- Bilateral hearing loss \> 40 dB uncorrected on an audiogram or having declared serious or severe hearing loss on Siopi questionnaire, with or without...
- New therapy introduced less than 2 months ago
- Psychatric disorders causing auditory hallucinations
See the full eligibility criteria
- Person who agreed to participate in the study and gave consent
- Aged ≥ 18 years and \< 85 years
- Suffering from subjective tinnitus for more than 3 months
- Have a score on the THI questionnaire taken at T0 greater than or equal to 38
- Be equipped with a smartphone compatible with the Siopi application and a computer connection for videoconference sessions
- Have answered the questionnaires on the Siopi application: THI, VAS-D and associated questions and insomnia severity index
- Have committed to diligently following the study protocol, including independent training
- Have agreed not to take other new treatments for tinnitus throughout the duration of the study
- Able to understand and carry out assessment instructions.
- Patient suffering from objective tinnitus
- Current port of white noise generators
- Patient having consulted phoniatrics more than twice or having participated in more than two sound-mediated workshop sessions
- Bilateral hearing loss \> 40 dB uncorrected on an audiogram or having declared serious or severe hearing loss on Siopi questionnaire, with or without prosthetic correction
- New therapy introduced less than 2 months ago
- Psychatric disorders causing auditory hallucinations
- Protected person (under guardianship or curatorship)
- Person under judicial protection
- Person deprived of liberty
- Person not affiliated to a social security system
- Pregnant or breastfeeding woman
- Person participating in a drug study
The study team makes the final eligibility decision.
Where it's taking place
- Orléans, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 84 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orléans, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.